Title
Comprehensive clinical care for men who have sex with men: An integrated approach
Date Issued
01 January 2012
Access level
open access
Resource Type
review
Author(s)
Mayer K.H.
Bekker L.G.
Stall R.
Grulich A.E.
Colfax G.
Publisher(s)
Elsevier
Abstract
Men who have sex with men (MSM) have unique health-care needs, not only because of biological factors such as an increased susceptibility to infection with HIV and sexually transmitted infections associated with their sexual behaviour, but also because of internalisation of societal stigma related to homosexuality and gender non-conformity, resulting in depression, anxiety, substance use, and other adverse outcomes. Successful responses to the global HIV/ AIDS epidemic will require the development of culturally sensitive clinical care programmes for MSM that address these health disparities and root causes of maladaptive behaviour (eg, societal homophobia). Health-care providers need to become familiar with local outreach agencies, hotlines, and media that can connect MSM with positive role models and social opportunities. Research is needed to understand how many MSM lead resilient and productive lives in the face of discrimination to develop assets-based interventions that build on community support. Optimum clinical care for sexual and gender minorities is a fundamental human right. MSM deserve to be treated with respect, and health-care providers need to interact with them in ways that promote disclosure of actionable health information.
Start page
378
End page
387
Volume
380
Issue
9839
Language
English
OCDE Knowledge area
Ciencias socio biomédicas (planificación familiar, salud sexual, efectos políticos y sociales de la investigación biomédica)
Scopus EID
2-s2.0-84864276501
PubMed ID
Source
The Lancet
ISSN of the container
01406736
Sponsor(s)
KHM has received unrestricted research and educational grants from Gilead Sciences, Bristol-Myers Squibb, and Merck. AEG has received honoraria and conference travel support from Merck and research funding from CSL, the Australian distributor of Gardisil. All other authors declare that they have no conflicts of interest. We would like to thank Andrea Karis for assistance in the preparation of the manuscript and Amy Herrick for preparation of the figure. KHM would also like to thank Rodney Vanderwarker, Harvey Makadon, Judith Bradford, Steven Safren, Matthew Mimiaga, Sean Cahill, Conall O'Cleirigh, and Stephen Boswell at Fenway Health, who assisted in thinking through the approach to many of the key issues discussed in this article. KHM is supported by the Harvard Center for AIDS Research (grant number P30AI-06354 ) and the National Institute of Allergy and Infectious Diseases Clinical Trial Unit for HIV Prevention and Microbicide Research ( UM1AI069480 ).
Sources of information: Directorio de Producción Científica Scopus